Simple, sensitive, selective and precise stability-indicating thin-layer chromatographic (TLC) andhigh-performance liquid chromatographic (HPLC) methodsfor the determination of Buflomedil (BFM) in pharmaceutical tablets were developed and validatedas per the International Conference on Harmonizationguidelines. The TLC method employs aluminum TLCplates precoated with silica gel 60F 254 as the stationary phase and Butanol: ammonia: triethylamine (8:0.5:0.5, v/v/v) as the mobile phase to give compact spots for Buflomedil (R f =0.55) and its degradation product (R f =0.05), the chromatogram was scanned at 272 nm. The HPLC method utilizes a C18 column and amobile phase consisting of methanol: water: acetonitrile: triethylamine (50:30:20:0.4, v/v, pH 6.5) at a flow rate of 0.7 mL min -1 for the separation of Buflomedil (t R =3.76) and its degradation product (t R =2.117). Quantitation was achieved with UV detection at 272 nm. The methods were validated in terms of accuracy, precision, linearity, limits of detection, and limits of quantification. Buflomedil was exposed to acid hydrolysis and analyzed by the proposed methods in presence of its degradation products. As the methods could effectively separate the drugs from their degradation products, these techniques can be employed as stability-indicating methods that have been successively applied to pharmaceutical formulations without interference from the excipients.
Introduction
Instability of pharmaceuticals affects both the safety andefficacy of drug therapy. Therefore, appropriate analyticalstability-indicating methods which allow accurate andprecise drug quantitation in the presence of its degradationproducts are needed in order to assess the stability ofpharmaceuticals. Recently, the development of stabilityindicatingmethods has increased enormously, and is evenbeing extended to drug combinations.
Buflomedil HCl (Figure 1 ), 4-(1-pyrrolidinyl)-1-(2,4,6-trimethoxyphenyl)-1-butanone hydrochloride, is a vasoactive agent which increase the peripheral and cerebral blood flow in ischaemic tissues of patients with vascular diseases particularly at the microcirculatory level [1] It is rapidly absorbed from the gastrointestinal tract, reaching maximal plasma concentration within 1.5-4 h.
There have been few reports for its determination in formulation and in biological fluids using gas chromatography [2] [3] [4] , highperformance liquid chromatography [5] [6] [7] and reversed-phase ionpair high-performance liquid chromatography [8, 9] which mainly concerned with poising or toxicological cases. Therefore, only few methods were determined of BFM in presence of its degradation products.
Experimental Instruments
The TLC-spectrodensitometry system: Camag TLC scanner 3 S/N 130319 operated with winCATS software, Linomat 5 autosampler (Switzerland), Camagmicrosyringe (100 µL) and TLC aluminum sheet (20×20 cm) precoated with silica gel 60 F 254 . (Merck KgaA, Darmstad, Germany) were used.
The HPLC system: Agilent 1200 series chromatographic system equipped with quaternary pump, microvacuum degasser, thermostatted column compartment and variable wavelength UV-VIS detector was used. Sample injections were made through an Agilent 1200 series autosampler. Data collection and processing were performed using Agilent ChemStation software, version A.10.01. Column Agilent Zorbax SB-C18 (150 mm×4.6 mm, 5 µm particle size i.d.) was from (Agilent Technologies, Polo Alto, CA, USA).
A "Jenway 3505" pH-meter (Jenway, UK), equipped with combined glass electrode was used for pH adjustment.
Chemicals and reagents
Pure sample: BFM was kindly supplied by Global Napi Pharmaceuticals (6 th October City, Egypt). The purity of the sample was found to be 99.99% according to reported HPLC method [10] . Reagents: All chemicals used throughout the work were of analytical grade and solvents were of spectroscopic and HPLC grade: methanol, acetonitrile, triethylamin (s d fine-chem limited, Industerial state, Mumbai), 5N aqueous hydrochloric acid solution and 10N Sodium hydroxide, toluene, propanol, Butanol, Glacial acetic acid and ammonia solution 33% (El-Nasr Pharmaceutical Chemicals Co., AbuZabaal, Cairo, Egypt), doubly distilled deionized water (Otsuka, Cairo, Egypt).
Standard solutions
• BFM stock standard solution: a stock solution containing 1 mgmL −1 in methanol was prepared by dissolving 100 mg of Buflomedil in sufficient amount of methanol and completing to 100 mL with the same solvent.
• BFM working standard solution: a volume of 20 mL of BFM stock standard solution (1 mgmL −1 ) were transferred into a 100 mL volumetric flask and the volume was completed to the mark with methanol to obtain 200 µgmL −1 final concentration.
• BFM acid induced degradation: a stock solution of degraded BFM was prepared as described under degraded samples [2.3.1.]
• Laboratory prepared mixtures: For TLC, solutions containing different ratios of drugs and their degradation products in methanol were prepared from their working solutions. For HPLC, the solutions were prepared from the working solutions and diluted with the mobile phase.
Procedures
Degraded samples: Degraded BFM sample was prepared by accurately weighing 50 mg of pure BFM, refluxed with 50 mL 5N HCl for 4 hours. The solution was then neutralized to pH 6.8-7.2 using 10N NaOH, Then evaporated under vacuum, extracted two times with 20 mL methanol, filtered with 50 mL volumetric flask and completed to volume with methanol to produce final concentration equivalent to 0.5 mgmL A 20-µL aliquot of eachsolution was injected onto a ZorbaxSB-C 18 column (150 mm×4.6 mm, 5 µm particle size i.d.); using the mobile phase, at flow rate 0.7 mLmin -1 and detection at 272 nm. The calibration curves were constructed by plotting the peak ratio, using 20 µgmL -1 of BFM as the external standard, and the corresponding concentration in micrograms per milliliter and the regression equation were computed.
Assay of laboratory-prepared mixtures: The peak areas or peak area ratios of the laboratory-prepared mixture were scanned and processed as described for the calibration for each of the proposed TLC or HPLC methods, respectively. The concentration of Buflomedil in each mixture was calculated using the specified regression equations.
Application to pharmaceutical formulations: Ten Loftyl
® tablets [labeled to contain 150 mg BFM] were accurately weighted and finely powdered. An accurate weight of the powdered tablet equivalent to 100 mg BFM were sonicated with 60 mL methanol for 20 min, filtered into a 100 mL volumetric flask and completed to volume with methanol. The obtained solution labeled to contain 1 mgmL −1 . A volume of 20 mL of previous stock solution were transferred into a 100 mL volumetric flask and the volume was completed to the mark with distilled water to obtain 200 µgmL −1 final concentration. For TLC, 10 µL was applied onto TLC plates, whereas for HPLC analysis, the last solution was further diluted by transferring 0.5-10 mL aliquots of it to 10-mL volumetric flasks and the volumes were completed with the HPLC mobile phase. The general procedures described above for each method were followed to determine the concentration of Buflomedil in the prepared dosage form solutions.
Results and Discussion
The development of analytical methods for the determination of compounds in the presence of their degradation products without previous chemical separation is always a matter of interest. A stabilityindicating method has been studied and validated for the determination of Buflomedil in presence of its degradation products [10] , acid degradation of BFM was carried out by refluxing with 5N HCl to give two main degradation products which are 1,3,5 Trimethoxybenzene and butane-pyrrolidinium salt [10] , (Figure 2 ).
Although stability-indicating methods have been extended to include determination of BFM in presence of its degradation products, our review of the literature indicated that these methods are much sensitive and no such TLC-densitometric method has been described for determination of BFM in presence of its degradation products.
TLC
In this work, a TLC densitometric method was used for the determination of BFM by separation from their degradation products, depending on the difference in R f values. Complete separation of BFM from its degradation products was achieved using Butanol: ammonia: triethylamine (8:0.5:0.5, v/v/v) as the mobile phase. Densitometric scanning was performed at 272 nm with accepted results (Figure 3a and b). Figure  4) . Several trials were done to reach the optimum chromatographic separation, and the suggested chromatographic system allows complete baseline separation in reasonable time [11, 12] .
HPLC

Good chromatographic separation of BFM from its degradation
Method validation
ICH guidelines for method validation were followed for validation of the suggested methods [11, 12] . Linearity and ranges: Under the previously described experimental conditions, linear relationships were obtained by plotting the drug concentrations against peak areas for each drug, for both chromatographic methods. The corresponding concentration ranges, calibration equations, LOD and LOQ and other statistical parameters are listed in Table 1 .
Accuracy:
The accuracy of the investigated methods was validated by analyzing pure samples of both BFM and its degradation products.
The concentrations of the BFM was calculated from the calculated regression equation. Good results are shown in Table 1 .
Precision: Precision was evaluated by calculating intra-and interday precision by repeating the assay of three different concentrations three times in the same day and assaying the same samples in triplicate on three successive days, using the developed chromatographic methods and calculating the recovery % and RSD%. Results in Table 1 indicate satisfactory precision of the proposed methods.
Specificity: Specificity was ascertained by analyzing different mixtures containing the BFM and its degradation products in different ratios. Other parameters such as resolution, capacity factor and selectivity for the separated spots and peaks were then calculated, Table  1 .
Application to commercial tablets:
The suggested methods were successfully applied for determination of Buflomedil inLoftyl ® tablets. The results shown in Table 2 were satisfactory and with good agreement with the labeled amounts. Applying the standard addition technique, no interference due to excipients was observed as shown from the results in Table 2 .
In order to validate the suggested chromatographic methods, an overall system suitability testing was done to determine ifthe operating systems are performing properly. Good results were obtained and shown in Table 3 and 4.
When results obtained by applying the proposed methods for analysis of pure BFM compared to those obtained by applying the reported method [10] , they showed no significant difference regarding accuracy and precision, and results were given in Table 5 .
In order to compare the ability of the proposed methods to determine pure BFM, the obtained results were subjected to statistical analysis using one-way ANOVA test, there was no significant difference between all of the proposed methods (Table 6 ). 
Conclusion
The proposed methods are simple and rapid methods of their analysis especially in quality control laboratories. The suggested chromatographic methods provide simple, accurate, and reproducible stability-indicating methods for the quantitative analysis in presence of degradation products. The developed TLC method is highly sensitive than the reported method [13] and has the advantages of short run time, large sample capacity, and use of minimal volume of solvents. The HPLC method gives a good resolution between the drug and its degradation product with suitable analysis time. It is highly specific. The applied methods could be useful for stability investigation of the active drug and checking the extent of degradation in pharmaceutical formulations.
